Last reviewed · How we verify

Intrauterine injection of hyaluronic acid

Barzilai Medical Center · Phase 1 active Small molecule

Intrauterine injection of hyaluronic acid is a Small molecule drug developed by Barzilai Medical Center. It is currently in Phase 1 development. Also known as: operative hysteroscopy -, diagnostic hysteroscopy.

At a glance

Generic nameIntrauterine injection of hyaluronic acid
Also known asoperative hysteroscopy -, diagnostic hysteroscopy
SponsorBarzilai Medical Center
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intrauterine injection of hyaluronic acid

What is Intrauterine injection of hyaluronic acid?

Intrauterine injection of hyaluronic acid is a Small molecule drug developed by Barzilai Medical Center.

Who makes Intrauterine injection of hyaluronic acid?

Intrauterine injection of hyaluronic acid is developed by Barzilai Medical Center (see full Barzilai Medical Center pipeline at /company/barzilai-medical-center).

Is Intrauterine injection of hyaluronic acid also known as anything else?

Intrauterine injection of hyaluronic acid is also known as operative hysteroscopy -, diagnostic hysteroscopy.

What development phase is Intrauterine injection of hyaluronic acid in?

Intrauterine injection of hyaluronic acid is in Phase 1.

Related